Thursday, March 14, 2013
Discoveries: The Next Generation
Student researchers were given the opportunity to showcase their work at the annual Student Research Week.
Written by Suzanna Cisneros
Tagde took home top honors in the Basic Sciences Senior category for his research on multiple myeloma, a cancer of the plasma cell.
Ashujit Tagde’s curiosity always got the best of him, so when it came time to decide what to pursue as a career, research was a perfect fit.
“Research could be fun, right from developing hypothesis, designing experiments, analyzing results and repeating the same procedure again until you find something new,” Tagde said. “It really gives a sense of accomplishment when you realize your work will make a positive impact of someone’s life.”
This drive and passion for research helped Tagde take top honors in the Basic Sciences Senior category at the 25th Annual Student Research Week. Students in the Graduate School of Biomedical Sciences use this opportunity to showcase the next generation of biomedical researchers and their work.
“The research activities at Student Research Week are increasingly diverse and intense,” Tagde said. “Student Research Week recognizes and celebrates research undertaken by students. This year, we had an overwhelming response from all campuses and schools, which reflects increasing awareness about the importance of research.”
Tagde, who is currently pursuing a Ph.D. in pharmacology, works in the School of Medicine Cancer Center and is mentored by Patrick Reynolds, M.D., Ph.D. His award-winning research focused on multiple myeloma, a cancer of the plasma cell. Every year nearly 20,000 patients are diagnosed with myeloma and 10,000 die because of the disease. In the last decade, nearly 7,000 patients in Texas died because of myeloma. The current treatment is aimed at slowing down progression, reducing tumor load and associated symptoms. The current induction therapy is based on Melphalan, a DNA alkylating agent.
Tagde said Melphalan is given in combination with other drugs. Although patients initially respond to a varying extent, all of them relapse at some time point during therapy. The reason for relapse is thought to be due to development of drug resistance and driven by intracellular antioxidant glutathione. The cancer cell exploits glutathione to overcome the anti-cancer effects of Melphalan.
“We are studying whether inhibiting glutathione production inside the cell could enhance the anti-cancer effect of Melphalan,” Tagde said. “So far, we have made significant headway in this direction and our experiments support this concept. Our study is initiating a Phase I clinical trial against advanced myeloma. The study has been presented at the American Association for Cancer Research and Cancer Prevention and Research Institute of Texas conference.”
Hall and Pandhare (right) were the student organizers of this year’s event.
Student Research Week also brought in keynote speakers Dan M. Roden, M.D., assistant vice chancellor for personalized medicine and director of the John Oates Institute for Experimental Therapeutics at Vanderbilt University School of Medicine, and Richard M. Weinshilboum, M.D., the Mary Lou and John H. Dasburg Professor in Cancer Genomics Research and chair of the Division of Clinical Pharmacology at the Mayo Clinic College of Medicine, to present this year’s theme, Genomic Revolution: Personalizing Medicine.
Akash Pandhare, event director, said this year’s goal was to learn more about the recent advances made in genomics and how this advancing field in research will allow accurate predictions to be made about a person’s susceptibility of developing a particular disease, the course of the disease and its response to treatment.
“The speakers are nationally known for their expertise in genomics research,” Pandhare said. “We were extremely excited and fortunate to have the high caliber of keynote lectures at this year’s event.”
Connor Hall, event marketing director, said Student Research Week is an opportunity for students, faculty and staff to learn about what research is being done at TTUHSC.
“Many people may not understand the world of research and what it encompasses,” Hall said. “This gave people the opportunity to see first hand how research is such a vital part of academics as well as the daily lives of everyone.”
Other Student Research Week award winners are:
- Basic Science Seniors
First: Ashujit Tagde
Second: Ahsan Farooqi
Third: Jood Hashem
- Basic Science Juniors
First: Ravi Rajmohan
First: James Wang
Second: Lauren Hubbard
- Clinical Sciences Seniors
First: Macym Rizvi
Second: Jaden Evans
Third: Trey Sertich
- Clinical Sciences Juniors
First: Jordan Jamerson
Second: Justin Berk
Third: Michael Matthews
First: Jessica Stilwell
Second: Tyler Enos
Third: Nyasha Gondora
- Resident and Clinical Fellows
First: Jarmara Hice
Second: Johnny Hickson
Third: Katherine Rinard
- Postdoctoral Fellows
First: Gurvinder Kuar
- Quality Enhancement Plan
First: Meera Subash
- Best Practices
First: Chelsea Lohman
Story produced by the Office of Communications and Marketing, (806) 743-2143.
Leave a Reply
Graduate School of Biomedical Sciences
The Graduate School of Biomedical Sciences, originally a part of the School of Medicine, became a separate school in 1994 to coordinate the training of biomedical scientists.
A small student body, a diverse faculty and a low student-faculty ratio are factors that promote learning and encourage interaction between students. These unique factors create a highly competitive environment for students applying each year.
Beginning in 1969 as Texas Tech University School of Medicine, TTUHSC now is a six-school university with campuses in Abilene, Amarillo, Dallas/Fort Worth, El Paso, Highland Lakes, Lubbock, Midland and Odessa.
TTUHSC has trained more than 10,000 health care professionals, and meets the health care needs of more than 2.5 million people in the 108 counties including those in the Texas Panhandle and eastern New Mexico.